Busse PJ, Christiansen SC. Hereditary Angioedema. N Engl J Med.2020;382:1136-48.
Lumry WR, Castaldo AJ, Vernon MK, Blaustein
MB, Wilson
DA, Horn
PT. The humanistic burden of hereditary angioedema: Impact on
health-related quality of life, productivity, and depression.Allergy Ast Proc. 2010;31(5):407-14.
Lumry WR, Settipane
RA.
Hereditary angioedema: Epidemiology and burden of disease.Allergy Asthma Proc. 2020;1;41(Suppl 1):S08-S13.
Bork K, Hardt J, Witzke G. Fatal laryngeal attacks and mortality in
hereditary angioedema due to C1-INH deficiency. J Allergy Clin
Immunol. 2012;130:692-97.
Osler W. Hereditary angio-neurotic oedema. Am J Med Sci.
1888;95:362–367.
Leibovich-Nassi I, Reshef A.
The Enigma of
Prodromes in Hereditary Angioedema (HAE). Clin Rev Allergy
Immunol. 2021; 61(1):15-28.
Kemp JG, Craig TJ. Variability of prodromal signs and symptoms
associated with hereditary angioedema attacks: a literature review.Allergy Ast Proc. 2009;30:493-499.
Prematta MJ, Kemp JG, Gibbs JG, Craig TJ. Frequency, timing, and type
of prodromal symptoms associated with hereditary angioedema attacks.Allergy Ast Proc. 2009;30:506-511.
Prematta MJ, Bewtra AK, Levy RJ,
Wasserman
RL, Jacobson
KW, Machnig
T,
et
al. Per-attack reporting of prodromal symptoms concurrent with
C1-inhibitor treatment of hereditary angioedema attacks. Adv
Ther. 2012;29(10):913-922.
Reshef A, Prematta M, Craig TJ. Signs and symptoms preceding acute
attacks of hereditary angioedema: results of three recent
surveys. Allergy Ast Proc. 2013;34(3):261-266.
Leibovich-Nassi I, Golander H, Somech R, Har-Even D, Reshef A.
New
Instrument for the Evaluation of Prodromes and Attacks of
Hereditary Angioedema (HAE-EPA). Clin Rev Allergy Immunol.2021;61(1):29-39.
Kaplan
AP,
Joseph
K. Pathogenesis of Hereditary Angioedema: The Role of the
Bradykinin-Forming Cascade.Immunol
Allergy Clin N Am. 2017;37(3):513-525.
Hofman ZLM, Relan A, Zeerleder S, Drouet C, Zuraw B, Hack CE.
Angioedema attacks in patients with hereditary angioedema: local
manifestations of a systemic activation process. J Allergy Clin
Immunol. 2016; 138:359-366.
Magerl M, Bader M, Gompel A, Joseph K, Kaplan AP,
Kojda
G et al. Bradykinin in health and disease: proceedings of the
Bradykinin Symposium 2012. Inflamm Res. 2014; 63:173-178.
Luyasu S, Charignon D, Ponard D, Drouet C, Ghannam A.
Angioedema:
Systemic activation process during prodromes. Ann Allergy Ast
Immunol. 2018;121(2):248-249.
Santana MJ, Feeny D. Framework to assess the effects of using
patient-reported outcome measures in chronic care
management. Qual Life Res. 2014;23:1505-13.
Nelson EC, Eftimovska E, Lind C et al, Patient Reported outcome
measures in practice. Brit Med J. 2015; 350: g7818.
Leibovich-Nassi I, Reshef A, Somech R, Golander H. A survey of
hereditary angioedema in Israel. Allergy, Ast Clin Immunol.
2017;13 (Suppl 2): 34
Barlow JH, Cullen A, Rowe IF. Comparison of knowledge and
psychological well-being between patients with a short disease
duration and patients with more established rheumatoid arthritis.Pat Edu Counsel. 1999; 38:195-203.
Scully JL. What is a disease? Disease, disability and their
definitions. Europ Moll Biology Organ Rep. 2004;5(7):650-653.
Lazarus R, Folkman S. Stress, Appraisal and Coping. New York,
Springer; 1984.
Maurer M, Aberer W, Bouillet L et al. Hereditary angioedema attacks
resolve faster and are shorter after early icatibant treatment.PLoS One. 2013;8(2):e53773.
Kelman L. The premonitory symptoms (prodrome): a tertiary care study
of 893 migraineurs. Headache. 2004;44(9): 865-872.
Schoonman GG, Evers DJ, Terwindt GM, van Dijk JG, Ferrari MD. The
prevalence of premonitory symptoms in migraine: a questionnaire study
in 461 patients. Cephalalgia. 2006;26:1209-1213
Houtveen JH, Sorbi MJ. Prodromal functioning of migraine patients
relative to their interictal state - An ecological momentary
assessment study. PLoS One. 2013;8(8).
Lidar M, Yaqubov M, Zaks N et al. The prodrome: a prominent yet
overlooked pre-attack manifestation of familial Mediterranean fever.J Rheumatol. 2006;33(6):1089-1092.
Babaoglu
H,
Varan
O,
Kucuk
H et al. On demand use of anakinra for attacks of familial
Mediterranean fever (FMF).Clin
Rheumatol. 2019; 38(2):577-581.
Kreiberg KB, Bygum A. Reporting through smartphone application results
in detailed data on acquired and hereditary angioedema attacks.Allergy. 2019; 74:1800-1802.
Maurer M, Magerl M, Ansotegui I, Aygoren-Pursun E, Betschel S, Bork K,
et al. The international WAO/EAACI guideline for the management of
hereditary angioedema- the 2017 revision and update. Allergy.2018;73:1575-96.
Betschel S, Badiou J, Binkley K et al. The International/ Canadian
Hereditary Angioedema Guideline. Allergy Ast Clin Immunol.
2019; 15:72.
Busse PJ, Christiansen SC, Riedl MA, Banerji A, Bernstein JA, Castaldo AJ, et
al. US HAEA Medical Advisory Board 2020 Guidelines for the Management
of Hereditary Angioedema. J Allergy Clin Immunol Pract. 2021;
9(1):132-150.e3.